Independent news has never been so important.

Did you know that you can get Democracy Now! delivered to your inbox every day? Sign up for our Daily News Digest today! Don't worry, we'll never share or sell your information.

CureVac COVID-19 Vaccine Shows Disappointing 47% Efficacy in Large Clinical Trial

HeadlineJun 17, 2021

The German drugmaker CureVac says its COVID-19 vaccine showed an efficacy of just 47% in a large clinical trial. The disappointing result is just below the 50% threshold set by the World Health Organization and far below the roughly 95% effectiveness shown by other mRNA vaccines produced by Pfizer and Moderna.

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation